Quest Diagnostics Incorporated

Healthcare · Diagnostics & Research

236.30$ -0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Quest Diagnostics Incorporated (DGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,043 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DGX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,885	1,861	1,899	1,943	1,931	1,936	1,884	1,919	1,889	1,839	1,891	1,953	1,956	1,926	1,822	1,827	2,786	3,002	2,720	2,550	2,774	2,744	2,611	2,453	2,486	2,333	2,331	2,338	2,295	2,288	2,366	2,397	2,488	2,621	2,652	2,761	2,816	2,806	2,895	3,043	11,560
Cost of Revenue	1,157	1,160	1,165	1,170	1,190	1,194	1,226	1,243	1,222	1,235	1,244	1,265	1,264	1,264	1,270	1,221	1,580	1,733	1,626	1,565	1,670	1,718	1,646	1,611	1,618	1,575	1,560	1,546	1,541	1,548	1,595	1,593	1,677	1,763	1,789	1,818	1,867	1,892	1,953	2,016	7,728
Gross Profit	728	701	734	773	741	742	658	676	667	604	647	688	692	662	552	606	1,206	1,269	1,094	985	1,104	1,026	965	842	868	758	771	792	754	740	771	804	811	858	863	943	949	914	942	1,027	3,832
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	409	400	437	437	423	453	363	351	354	356	384	362	362	349	347	360	396	447	407	429	427	464	425	422	464	531	439	416	376	407	440	416	448	466	476	486	501	486	504	529	2,020
Total Operating Expenses	406	425	455	454	443	473	386	371	363	380	399	381	379	299	377	323	488	474	434	452	452	490	452	454	476	623	466	444	412	473	471	449	481	497	517	505	563	523	543	568	2,197
Operating Income	322	276	279	319	298	269	272	305	304	220	248	307	313	363	175	283	718	795	660	533	652	536	513	388	392	135	305	348	342	267	300	355	330	361	346	438	386	391	399	459	1,635
Interest Expense	37	36	37	38	39	39	41	43	42	43	45	46	45	44	42	42	42	40	38	38	38	38	37	38	37	36	37	39	41	46	49	47	58	72	72	69	69	67	63	63	262
Pre-Tax Income	289	242	246	292	258	234	229	264	266	167	213	265	270	337	132	259	768	800	643	827	680	527	483	327	357	112	282	324	305	245	274	314	302	304	294	393	336	337	334	412	1,419
Income Tax Expense	95	84	78	94	92	-23	52	42	48	40	50	63	62	72	26	66	177	191	153	177	153	114	110	77	81	-4.0	65	75	68	40	66	74	65	68	59	97	77	81	74	88	320
Net Income	190	155	163	193	160	253	176	219	212	126	163	206	214	253	99	184	566	576	468	628	503	389	354	233	254	101	202	235	225	192	194	229	226	222	220	282	245	245	252	320	1,062
EBITDA	389	341	345	396	366	347	344	384	384	287	342	392	397	454	245	386	884	896	765	955	793	646	595	466	496	261	421	468	451	392	431	478	479	507	488	596	547	546	434	481	2,008

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings